González-López, Marcos A. http://orcid.org/0000-0003-2423-5800
Vilanova, Iosune
Ocejo-Viñals, Gonzalo
Arlegui, Rubén
Navarro, Iñigo
Guiral, Sandra
Mata, Cristina
Pérez-Paredes, M. Genma
Portilla, Virginia
Corrales, Alfonso
González-Vela, M. Carmen
González-Gay, Miguel A.
Blanco, Ricardo
Hernández, José L.
Funding for this research was provided by:
This study was funded through an unrestricted grant provided by AbbVie. (0)
Article History
Received: 15 August 2019
Revised: 29 October 2019
Accepted: 20 November 2019
First Online: 30 November 2019
Compliance with ethical standards
:
: Dr. Marcos A. González López had consultation fees/participation in company sponsored speaker’s bureau from Abbvie. Dr. MA Gonzalez-Gay received grants/research supports from Abbvie, MSD and Roche, and had consultation fees/participation in company sponsored speaker ́s bureau from Pfizer, Lilly, Roche and Sanofi. Dr. R Blanco received grants/research supports from Abbvie, MSD and Roche, and had consultation fees/participation in company sponsored speaker ́s bureau from Abbvie, Pfizer, Roche, Bristol Myers, Janssen and MSD. The rest of the authors have no conflict of interest to declare regarding this paper.
: The research protocol was approved by the Ethics Committee of Cantabria (Spain). All study procedures were performed in accordance with the ethical principles of the 1964 Declaration of Helsinki and written informed consent was obtained from all the subjects.